ArticleAnnals of hematology2026

Asciminib and pulsed ATRA as post-remission therapy in T315I mutated PML-RARA-positive blast crisis of chronic myeloid leukemia.

Roberta Mazzarella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.